Literature DB >> 19520974

High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions.

Mihaela G Ionita1, Aryan Vink, I Esmé Dijke, Jon D Laman, Wouter Peeters, Petra Homoet van der Kraak, Frans L Moll, Jean-Paul P M de Vries, Gerard Pasterkamp, Dominique P V de Kleijn.   

Abstract

OBJECTIVE: Atherosclerotic plaque rupture can lead to severe complications such as myocardial infarction and stroke. Myeloid related protein (Mrp)-14, Mrp-8, and Mrp-8/14 complex are inflammatory markers associated with myocardial infarction. It is, however, unknown whether Mrps are associated with a rupture-prone plaque phenotype. In this study, we determined the association between Mrp-14, -8, -8/14 plaque levels and plaque characteristics. METHODS AND
RESULTS: In 186 human carotid plaques, levels of Mrp-14, -8, and -8/14 were quantified using ELISA. High levels of Mrp-14 were found in lesions with a large lipid core, high macrophage staining, and low smooth muscle cell and collagen amount. Plaques with high levels of Mrp-14 contained high interleukin (IL)-6, IL-8, matrix metalloprotease (MMP)-8, MMP-9, and low MMP-2 concentrations. Mrp-8 and Mrp-8/14 showed a similar trend. Within plaques, a subset of nonfoam macrophages expressed Mrp-8 and Mrp-14 and the percentage of Mrp-positive macrophages was higher in rupture-prone lesions compared to stable ones. In vitro, this subset of macrophages does not acquire a foamy phenotype when fed oxLDL.
CONCLUSIONS: Mrp-14 is strongly associated with the histopathologic features and the inflammatory status of rupture-prone atherosclerotic lesions, identifying Mrp-14 as a local marker for these plaques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520974     DOI: 10.1161/ATVBAHA.109.190314

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  31 in total

1.  In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.

Authors:  Andrei Maiseyeu; Marcus A Badgeley; Thomas Kampfrath; Georgeta Mihai; Jeffrey A Deiuliis; Cuiqing Liu; Qinghua Sun; Sampath Parthasarathy; Daniel I Simon; Kevin Croce; Sanjay Rajagopalan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

2.  The elevated serum S100A8/A9 during acute myocardial infarction is not of cardiac myocyte origin.

Authors:  Chang-Qing Du; Lin Yang; Jie Han; Jian Yang; Xue-Yan Yao; Xiao-Sheng Hu; Shen-Jiang Hu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea.

Authors:  Rakesh Bhattacharjee; Jinkwan Kim; Wadha H Alotaibi; Leila Kheirandish-Gozal; Oscar Sans Capdevila; David Gozal
Journal:  Chest       Date:  2011-10-26       Impact factor: 9.410

Review 4.  What have we learned about plaque rupture in acute coronary syndromes?

Authors:  So-Yeon Choi; Gary S Mintz
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

5.  S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE-/- mice.

Authors:  Jooneon Park; Huiyun Gao; Yunmei Wang; He Hu; Daniel I Simon; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2019-02-13       Impact factor: 6.331

6.  Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.

Authors:  Stephen D Farris; Jie Hong Hu; Ranjini Krishnan; Isaac Emery; Talyn Chu; Liang Du; Michal Kremen; Helén L Dichek; Elizabeth Gold; Stephen A Ramsey; David A Dichek
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

Review 7.  Consolidated and emerging inflammatory markers in coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-02-20

8.  S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation.

Authors:  Michelle M Averill; Shelley Barnhart; Lev Becker; Xin Li; Jay W Heinecke; Renee C Leboeuf; Jessica A Hamerman; Clemens Sorg; Claus Kerkhoff; Karin E Bornfeldt
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

9.  A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?

Authors:  Jin Wen; Yan Wen; Li Zhiliang; Chen Lingling; Cao Longxing; Wang Ming; Fu Qiang
Journal:  Heart Vessels       Date:  2012-01-07       Impact factor: 2.037

10.  10-years experience with the Athero-Express study.

Authors:  Willem E Hellings; Frans L Moll; Dominique P V de Kleijn; Gerard Pasterkamp
Journal:  Cardiovasc Diagn Ther       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.